Cargando…

Introduction: Real-World Evidence in Type 2 Diabetes

Detalles Bibliográficos
Autores principales:	Hassanein, Mohamed, Amod, Aslam, Khunti, Kamlesh, Lee, Moon-Kyu, Mohan, Viswanathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415044/ https://www.ncbi.nlm.nih.gov/pubmed/32440834 http://dx.doi.org/10.1007/s13300-020-00832-y

Ejemplares similares

Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives
por: Khunti, Kamlesh, et al.
Publicado: (2020)

The Role of Real-World Evidence in Treatment Decision-Making, Regulatory Assessment, and Understanding the Perspectives of People with Type 2 Diabetes: Examples with Gliclazide MR
por: Khunti, Kamlesh, et al.
Publicado: (2023)

The multimorbidity epidemic: challenges for real-world research
por: Adan, Muna, et al.
Publicado: (2020)

The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm
por: Mohan, Viswanathan, et al.
Publicado: (2019)

The interdisciplinary team in type 2 diabetes management: Challenges and best practice solutions from real-world scenarios
por: McGill, Margaret, et al.
Publicado: (2016)

Introduction to real-world evidence studies
por: Chodankar, Deepa
Publicado: (2021)

Efficacy and Safety of IDegLira in Participants with Type 2 Diabetes in India Uncontrolled on Oral Antidiabetic Drugs and Basal Insulin: Data from the DUAL Clinical Trial Program
por: Khunti, Kamlesh, et al.
Publicado: (2017)

The quality of research with real-world evidence
por: Palacios, Mauricio
Publicado: (2019)

The Disruptive Force of Real-World Evidence
por: Schmitt-Egenolf, Marcus
Publicado: (2023)

The real-world impact of National Institute for Health and Care Excellence's real-world evidence framework
por: Duffield, Stephen, et al.
Publicado: (2023)

Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
por: Blonde, Lawrence, et al.
Publicado: (2018)

Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia
por: Khunti, Sachin, et al.
Publicado: (2019)

Diabetes prevention: A call to action
por: Yates, Tom, et al.
Publicado: (2011)

Early Identification of Type 2 Diabetes: Policy should be aligned with health systems strengthening
por: Narayan, K.M. Venkat, et al.
Publicado: (2011)

Global accessibility of therapeutics for diabetes mellitus
por: Fralick, Michael, et al.
Publicado: (2022)

Risk of Diabetes Following COVID-19: Translating Evidence Into Clinical and Public Health Actions
por: Zaccardi, Francesco, et al.
Publicado: (2022)

Efficacy of a Combination of Metformin and Vildagliptin in Comparison to Metformin Alone in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Evidence Study
por: Mohan, Viswanathan, et al.
Publicado: (2021)

Real World Evidence — Need for Physician-Scientist/Clinician-Researcher
por: Meeta, Meeta, et al.
Publicado: (2021)

The Increasing Importance of Rigorous Real-World Evidence
por: Yang, David D, et al.
Publicado: (2022)

The Role of Real-World Evidence to Support Treatment Choices in Malignant Pleural Mesothelioma
por: Wheatley-Price, Paul, et al.
Publicado: (2022)

Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on?
por: Carter, Patrice, et al.
Publicado: (2012)

Long covid: risk factors, outcomes, and future directions for research
por: O'Mahoney, Lauren, et al.
Publicado: (2022)

Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project
por: Gallacher, John, et al.
Publicado: (2019)

The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes
por: Moon, Jun Sung, et al.
Publicado: (2013)

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting
por: Meneghini, Luigi F., et al.
Publicado: (2019)

Type 2 Diabetes Mellitus Increases Peritonsillar Abscess Susceptibility: Real-World Evidence
por: Wu, Ching-Lung, et al.
Publicado: (2021)

Real World Evidence: Can We Really Expect It to Have Much Influence?
por: Evans, Keith
Publicado: (2019)

Precision diabetes: Where do we stand today?
por: Mohan, Viswanathan, et al.
Publicado: (2018)

The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
por: Davies, Melanie, et al.
Publicado: (2016)

Eating speed and the risk of type 2 diabetes: explorations based on real-world evidence
por: Gudi, Sai Krishna
Publicado: (2020)

A Review of Exenatide: Optimizing Glycemic Control and Associated Cardiovascular Risk Factors in Type 2 Diabetes
por: Htike, Zin Z., et al.
Publicado: (2012)

Evidence for Mechanistic Alterations of Ca(2+) Homeostasis in Type 2 Diabetes Mellitus
por: Balasubramanyam, Muthuswamy, et al.
Publicado: (2000)

Digital Health and Big Data Analytics: Implications of Real-World Evidence for Clinicians and Policymakers
por: Magalhães, Teresa, et al.
Publicado: (2022)

Comparison of efficacy between incretin-based therapies for type 2 diabetes mellitus
por: Nisal, Kaustubh, et al.
Publicado: (2012)

Experiences of using a digital type 2 diabetes prevention application designed to support women with previous gestational diabetes
por: Ekezie, Winifred, et al.
Publicado: (2021)

Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
por: Menzen, Markus, et al.
Publicado: (2023)

Drugs: Real World Outcomes
por: Peters, Dene C., et al.
Publicado: (2014)

Real‐world effectiveness of antipsychotics
por: Tiihonen, J.
Publicado: (2016)

Bridging the Gap between Evidence and Real-World Practice for Liver Cancer Screening in South Korea
por: Oh, Chang-Mo
Publicado: (2020)

Erratum: Eating speed and the risk of type 2 diabetes: explorations based on real-world evidence
por: Gudi, Sai Krishna
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kp7vig5nihrevld8jfq34u2p3v